Estrogen receptor-positive (ER+) breast cancer remains a major challenge even with well-defined treatment options. The ...

Sunrock Biopharma SL and Shanghai Escugen Biotechnology Co. Ltd. have joined forces in a strategic partnership to codevelop ...

Sales of the vaccine have been declining due to weak demand trends in China amid an economic slowdown. Gardasil sales ...

A newly approved shot could soon help protect babies from respiratory syncytial virus, the top cause of hospitalization in US infants.

Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...